RECORD // Company

Collegium Pharmaceutical, Inc

Formerly: COLLEGIUM PHARMACEUTICAL INC

Built 2026-11-22T00:49:47Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (2 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

Gleif lei (1)
SEC EDGAR (1)
Matched by name only, not merged (9)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

7 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-05 · accession 0001628280-26-070589

ItemValuePeriodFormFiledAccessionReport
Revenue$216,339,0003 months ended 2026-09-3010-Q2026-11-050001628280-26-0705892026-11-22 00:49 UTCReport an error
Net income (loss)$21,759,0003 months ended 2026-09-3010-Q2026-11-050001628280-26-0705892026-11-22 00:49 UTCReport an error
Interest expense$21,943,0003 months ended 2026-09-3010-Q2026-11-050001628280-26-0705892026-11-22 00:49 UTCReport an error
Cash and cash equivalents$144,797,000at 2026-09-3010-Q2026-11-050001628280-26-0705892026-11-22 00:49 UTCReport an error
Contract liabilities (total)$10,393,000at 2026-09-3010-Q2026-11-050001628280-26-0705892026-11-22 00:49 UTCReport an error
Contract liabilities, current$1,782,000at 2026-09-3010-Q2026-11-050001628280-26-0705892026-11-22 00:49 UTCReport an error
Contract liabilities, noncurrent$8,611,000at 2026-09-3010-Q2026-11-050001628280-26-0705892026-11-22 00:49 UTCReport an error

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001267565
Ticker
COLL
UEI
DMDLZN7GH8R7
CUSIP
19459J104
Record ID
sx:sec:0001267565

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

36 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-16SEC EDGAR company profile2026-11-22 00:49 UTCReport an error
SIC industry2834 Pharmaceutical Preparations2026-11-16SEC EDGAR company profile2026-11-22 00:49 UTCReport an error
State of incorporationVA2026-11-16SEC EDGAR company profile2026-11-22 00:49 UTCReport an error
Fiscal year end (MMDD)12312026-11-16SEC EDGAR company profile2026-11-22 00:49 UTCReport an error
Business address100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 020722026-11-16SEC EDGAR company profile2026-11-22 00:49 UTCReport an error
ExchangesNasdaq2026-11-16SEC EDGAR company profile2026-11-22 00:49 UTCReport an error
Revenue (fiscal year ended 2025-12-31)$780,567,0002025-12-3110-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax2026-11-22 00:49 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$62,870,0002025-12-3110-K, XBRL NetIncomeLoss2026-11-22 00:49 UTCReport an error
Total assets (at 2025-12-31)$1,656,834,0002025-12-3110-K, XBRL Assets2026-11-22 00:49 UTCReport an error
Stockholders' equity (at 2025-12-31)$301,675,0002025-12-3110-K, XBRL StockholdersEquity2026-11-22 00:49 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$231,252,0002025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-22 00:49 UTCReport an error
Operating cash flow (fiscal year ended 2025-12-31)$329,323,0002025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-22 00:49 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31)$1,740,0002025-12-3110-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment2026-11-22 00:49 UTCReport an error
Operating lease liabilities (at 2025-12-31)$5,539,0002025-12-3110-K, XBRL OperatingLeaseLiability2026-11-22 00:49 UTCReport an error
Form D total offering amount (D filed 2018-11-13)$20,000,0062018-11-13D2026-11-22 00:49 UTCReport an error
Form D total amount sold (D filed 2018-11-13)$20,000,0062018-11-13D2026-11-22 00:49 UTCReport an error
Form D industry groupPharmaceuticals2018-11-13D2026-11-22 00:49 UTCReport an error
Form D revenue rangeDecline to Disclose2018-11-13D2026-11-22 00:49 UTCReport an error
Form D date of first sale2018-11-082018-11-13D2026-11-22 00:49 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-11-05)On November 5, 2026, Collegium Pharmaceutical, Inc. (the “Company”) issued a press release announcing its financial results for the quarterly period ended September 30, 2026. The full text of the press release issued in connection with the announcement is attached hereto as Exhibit 99.1 and is being furnished, not filed, under Item 2.02 of this Current Report on Form 8-K.2026-11-05SEC EDGAR 8-K 0001628280-26-070585 (text as filed, excerpt)2026-11-22 00:49 UTCReport an error
8-K Item 7.01, Regulation FD Disclosure (filed 2026-11-05)On November 5, 2026, Collegium Pharmaceutical, Inc. released an earnings presentation. The presentation is attached hereto as Exhibit 99.2 and is being furnished, not filed, under Item 7.01 of this Current Report on Form 8-K.2026-11-05SEC EDGAR 8-K 0001628280-26-070585 (text as filed, excerpt)2026-11-22 00:49 UTCReport an error
8-K Item 1.02 (filed 2026-10-19)Termination of a Material Definitive Agreement. As previously disclosed, Collegium Pharmaceutical, Inc. (the “Company”) is party to a License Agreement (U.S.), dated as of January 13, 2015, with Grünenthal GmbH (“Grünenthal”) (as amended, the “Grünenthal License”) which the Company assumed pursuant to a Consent Agreement, dated as of January 30, 2020 between the Company, Grünenthal and Assertio Therapeutics, Inc. (the “Consent Agreement”) as part of the Company’s 2020 acquisition of Nucynta ER and Nucynta IR (the “Nucynta Products”). As also previously disclosed, in February 2026, Grünenthal filed a complaint in the United States District Court for the District of New Jersey, naming the…2026-10-19SEC EDGAR 8-K 0001104659-26-116876 (text as filed, excerpt)2026-11-22 00:49 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-08-06)On August 6, 2026, Collegium Pharmaceutical, Inc. (the “Company”) issued a press release announcing its financial results for the quarterly period ended June 30, 2026. The full text of the press release issued in connection with the announcement is attached hereto as Exhibit 99.1 and is being furnished, not filed, under Item 2.02 of this Current Report on Form 8-K.2026-08-06SEC EDGAR 8-K 0001628280-26-053849 (text as filed, excerpt)2026-11-22 00:49 UTCReport an error
8-K Item 7.01, Regulation FD Disclosure (filed 2026-08-06)On August 6, 2026, Collegium Pharmaceutical, Inc. released an earnings presentation. The presentation is attached hereto as Exhibit 99.2 and is being furnished, not filed, under Item 7.01 of this Current Report on Form 8-K.2026-08-06SEC EDGAR 8-K 0001628280-26-053849 (text as filed, excerpt)2026-11-22 00:49 UTCReport an error
Largest institutional holder #1 (13F as filed): BlackRock, Inc.$196,971,5122026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:49 UTCReport an error
Largest institutional holder #2 (13F as filed): Jupiter Topco LLC$77,743,4932026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:49 UTCReport an error
Largest institutional holder #3 (13F as filed): Invesco Ltd.$68,146,4642026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:49 UTCReport an error
Largest institutional holder #4 (13F as filed): FULLER & THALER ASSET MANAGEMENT, INC.$59,106,6622026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:49 UTCReport an error
Largest institutional holder #5 (13F as filed): PRINCIPAL FINANCIAL GROUP INC$59,091,4332026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:49 UTCReport an error
Largest institutional holder #6 (13F as filed): STATE STREET CORP$55,345,4922026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:49 UTCReport an error
Largest institutional holder #7 (13F as filed): MASSACHUSETTS FINANCIAL SERVICES CO /MA/$50,881,5252026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:49 UTCReport an error
Largest institutional holder #8 (13F as filed): VANGUARD CAPITAL MANAGEMENT LLC$50,001,6482026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:49 UTCReport an error
Largest institutional holder #9 (13F as filed): RENAISSANCE TECHNOLOGIES LLC$49,469,0742026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:49 UTCReport an error
Largest institutional holder #10 (13F as filed): EVENTIDE ASSET MANAGEMENT, LLC$49,272,7462026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:49 UTCReport an error
Federal award transactions, fiscal year 2026 (this one registration only)$02026-09-30USAspending recipient profile2026-11-22 00:49 UTCReport an error
Number of federal award transactions, fiscal year 2026 (this one registration only)52026-09-30USAspending recipient profile2026-11-22 00:49 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.